• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光辅助光动力疗法:两种提高治疗效果的新方案。

Laser-Assisted Photodynamic Therapy: Two Novel Protocols for Enhanced Treatment Results.

作者信息

Stevenson Mary L, Karen Julie K, Hale Elizabeth K

出版信息

J Drugs Dermatol. 2017 Apr 1;16(4):329-331.

PMID:28403266
Abstract

Photodynamic therapy (PDT) uses a topical photosensitizing agent which is activated by a light source to cause destruction of specific cells. Commonly used for the treatment of actinic keratoses and photodamage, PDT can also be used for other conditions including acne and sebaceous hyperplasia. Here we report our experience with two treatment protocols. The first protocol utilizes laser assisted delivery of topical 5-aminolevulinic acid for enhanced efficacy of blue light photodynamic therapy in the treatment of actinic keratoses and photodamage. The second protocol utilizes red light photodynamic therapy followed by pulsed dye laser to effectively target sebaceous glands in patients with extensive sebaceous hyperplasia.

J Drugs Dermatol. 2017;16(4):329-331.

.
摘要

光动力疗法(PDT)使用一种局部光敏剂,该光敏剂由光源激活以破坏特定细胞。PDT通常用于治疗光化性角化病和光损伤,也可用于其他病症,包括痤疮和皮脂腺增生。在此,我们报告我们在两种治疗方案中的经验。第一种方案利用激光辅助递送局部5-氨基酮戊酸,以提高蓝光光动力疗法治疗光化性角化病和光损伤的疗效。第二种方案采用红光光动力疗法,随后进行脉冲染料激光治疗,以有效靶向广泛皮脂腺增生患者的皮脂腺。

《皮肤药物学杂志》。2017年;16(4):329 - 331。

相似文献

1
Laser-Assisted Photodynamic Therapy: Two Novel Protocols for Enhanced Treatment Results.激光辅助光动力疗法:两种提高治疗效果的新方案。
J Drugs Dermatol. 2017 Apr 1;16(4):329-331.
2
Prospective study of intense pulsed light versus pulsed dye laser with or without blue light in the activation of PDT for the treatment of actinic keratosis and photodamage.强脉冲光与脉冲染料激光联合或不联合蓝光光动力疗法治疗光化性角化病和光损伤的前瞻性研究。
Lasers Surg Med. 2022 Jan;54(1):66-73. doi: 10.1002/lsm.23492.
3
Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.用于光化性角化病/光化性唇炎/痤疮的氨基乙酰丙酸光动力疗法:血管激光
Dermatol Clin. 2007 Jan;25(1):25-33. doi: 10.1016/j.det.2006.09.003.
4
Daylight photodynamic therapy: the Southern California experience.日光光动力疗法:南加州的经验。
Lasers Surg Med. 2015 Feb;47(2):168-72. doi: 10.1002/lsm.22323. Epub 2015 Feb 6.
5
Two-Step Irradiance Treatment Can Achieve Excellent Pain Control During Red Light 5-Aminolevulinic Acid Photodynamic Therapy for Actinic Keratoses.两步辐照治疗在红光5-氨基酮戊酸光动力疗法治疗光化性角化病过程中可实现出色的疼痛控制。
Photomed Laser Surg. 2018 Mar;36(3):174-176. doi: 10.1089/pho.2017.4351. Epub 2017 Dec 11.
6
Topical photodynamic therapy for dermatologic disorders: results and complications.用于皮肤病的局部光动力疗法:结果与并发症
J Drugs Dermatol. 2007 Dec;6(12):1197-202.
7
Multiple sequential light and laser sources to activate aminolevulinic acid in the treatment of photodamage: A retrospective study.用于光损伤治疗中激活氨基乙酰丙酸的多个连续光和激光源:一项回顾性研究。
J Cosmet Laser Ther. 2015;17(5):252-8. doi: 10.3109/14764172.2015.1022187.
8
5-Aminolevulinic acid photodynamic therapy with and without Er:YAG laser for actinic keratosis: Changes in immune infiltration.5-氨基酮戊酸光动力疗法联合或不联合铒:钇铝石榴石激光治疗光化性角化病:免疫浸润的变化。
Photodiagnosis Photodyn Ther. 2019 Jun;26:270-276. doi: 10.1016/j.pdpdt.2019.04.010. Epub 2019 Apr 12.
9
Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?10种治疗光化性角化病的有效光动力疗法方案的比较:有效光剂量和局部损伤在预测3个月时的完全缓解率方面有多大相关性?
Lasers Surg Med. 2018 Jul;50(5):576-589. doi: 10.1002/lsm.22827. Epub 2018 Apr 18.
10
The use of photodynamic therapy for treatment of acne vulgaris.光动力疗法用于寻常痤疮的治疗。
Dermatol Clin. 2007 Jan;25(1):47-57. doi: 10.1016/j.det.2006.09.014.

引用本文的文献

1
Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events.激光辅助药物递送:安全性与不良事件的系统评价
Pharmaceutics. 2022 Dec 7;14(12):2738. doi: 10.3390/pharmaceutics14122738.